Siemens Healthineers, DE000SHL1006

Siemens Healthineers stock after-hours at EUR 37.45: minus 1.14 percent after the Xetra close

Published on 10/05/2026 at 19:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Siemens Healthineers stock was at EUR 37.45 after-hours at 7:04 p.m. CEST on October 5, 2026, down 1.14 percent versus the Lang & Schwarz prior close. The company recently launched a blood-clot testing assay.

3D-Architekturrender eines modernen Glas-Bürogebäudes mit Grünanlagen
Siemens Healthineers DE000SHL1006 illustriert modernes Architektur-Render eines unmarkierten Glas-Bürocampus mit gepflegten Grünflächen und Platz, Illustration mit AI erstellt.

Siemens Healthineers stock was at EUR 37.45 after-hours at 7:04 p.m. CEST on October 5, 2026, according to Lang & Schwarz. That was minus 1.14 percent versus the Lang & Schwarz prior close of EUR 37.88 on October 2, 2026.

Trading day in Frankfurt

The Siemens Healthineers share was quoted after the Xetra close at the stated Lang & Schwarz price. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Siemens Healthineers stock.

New diagnostic assay launched

On September 29, 2026, Siemens Healthineers announced the global launch of its Innovance D-Dimer 2.0 assay. The company said the blood test is CE-marked, has received FDA 510(k) clearance and is intended to help assess patients with suspected venous thromboembolism, including deep vein thrombosis and pulmonary embolism.

Share buyback disclosure

In a September 21, 2026 capital-market disclosure, Siemens Healthineers AG reported that it bought back 89,988 shares between September 14 and September 20, 2026. The disclosure said cumulative purchases under the buyback totaled 3,214,359 shares from June 1 through September 20, 2026.

Disclaimer...

en | DE000SHL1006 | SIEMENS HEALTHINEERS | boerse | 70235363 | bgmi